Publications

Ntawuyirushintege S, Ahmed A, Bucyibaruta G, Siddig E.E, Remera E, Tediosi F, Wyss K. Spatiotemporal trends in stunting prevalence among children aged two years old in Rwanda (2020–2024): a retrospective analysis. Nutrients. 2025;17(17):2808. DOI: 10.3390/nu17172808

Signorell A, van Heerden A, Ayakaka I, Jacobs B.K, Antillon M, Tediosi F, Verjans A, Brugger C, Harkare H.V, Labhardt N.D, Bosman S, Kamele M, Keitseng M, Madonsela T, Kurscheid J, Muhairwe J, Keter A.K, Murphy K, van Ginneken B, Gils T, Katende B, Gebresenbet R.F, Erhardt R.M, Zoller T, Vanobberghen F, Glass T.R, Lynen L, Reither K. Effectiveness and cost-effectiveness of community-based TB screening algorithms using computer-aided detection (CAD) technology alone compared with CAD combined with point-of-care C reactive protein testing in Lesotho and South Africa: protocol for a pair. BMJ Open. 2025;15(7):e093989. DOI: 10.1136/bmjopen-2024-093989

Tani K, Mtenga S, Fink G, Tediosi F. Healthcare managers' perspectives on direct health facility financing in Tanzania. PLOS Glob Public Health. 2025;5(5):e0003772. DOI: 10.1371/journal.pgph.0003772

Abraham E, Gray C, Fagbamigbe A.F, Tediosi F, Osetinsky B, Haafkens J, Mhalu G, Mtenga S. Barriers and facilitators to health insurance enrolment among people working in the informal sector in Morogoro, Tanzania. AAS Open Res. 2024;4(in press). DOI: 10.12688/aasopenres.13289.2

Anyanwu U, Dimov A, Zinsstag J, Tediosi F, Markosyan T. Profitability and cost-effectiveness analysis of brucellosis control in Armenia: a One Health approach. CABI One Health. 2024;3(1). DOI: 10.1079/cabionehealth.2024.0010

Ehteshami F, Cassidy R, Tediosi F, Fink G, Cobos Muñoz D. Combining theory-driven realist approach and systems thinking to unpack complexity of type 2 diabetes and hypertension management in low and middle-income countries: protocol for a realist review. Systems. 2024;12(1):16. DOI: 10.3390/systems12010016

Harkare H.V, Osetinsky B, Ginindza N, Cindzi B.T, Mncina N, Akomolafe B, Marowa L.R, Ntshalintshali N, Tediosi F. Human and financial resource needs for universal access to WHO-PEN interventions for diabetes and hypertension care in Eswatini: results from a time-and-motion and bottom-up costing study. Hum Resour Health. 2024;22:32. DOI: 10.1186/s12960-024-00913-0

Lin Y, Walker A, Batta M, Ottilie-Kovelman S, Duchenko A, Brugger C, Keiser O, Wallis R.S, Reither K, Tediosi F, Antillón M. Economic burden of chronic obstructive pulmonary disease and post-tuberculosis sequelae in low- and middle-income countries: a database compiled from a systematic review and meta-analysis. BMJ Public Health. 2024;2:e000441. DOI: 10.1136/bmjph-2023-000441

Osei Afriyie D, Loo P.S, Kuwawenaruwa A, Kassimu T, Fink G, Tediosi F, Mtenga S. Understanding the role of the Tanzania national health insurance fund in improving service coverage and quality of care. Soc Sci Med. 2024;347:116714. DOI: 10.1016/j.socscimed.2024.116714

Snijders R, Shaw A.P.M, Selby R, Tirados I, Bessell P.R, Fukinsia A, Miaka E, Tediosi F, Hasker E, Antillón M. The cost of sleeping sickness vector control in Yasa Bonga, a health district in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2024;18(11):e0011959. DOI: 10.1371/journal.pntd.0011959

Tani K, Osetinsky B, Mhalu G, Mtenga S, Fink G, Tediosi F. Seeking and receiving hypertension and diabetes mellitus care in Tanzania. PLoS One. 2024;19(11):e0312258. DOI: 10.1371/journal.pone.0312258

Tani K, Osetinsky B, Mtenga S, Fink G, Tediosi F. Patient's willingness to pay for improved community health insurance in Tanzania. Health Policy Open. 2024;7:100130. DOI: 10.1016/j.hpopen.2024.100130

Tediosi F, Villa S, Levison D, Ekeman E, Politi C. Leveraging global investments for polio eradication to strengthen health systems' resilience through transition. Health Policy Plan. 2024;39(Suppl. 1):i93-i106. DOI: 10.1093/heapol/czad093

Verjans A, Hooley B, Tani K, Mhalu G, Tediosi F. Cross-sectional study of the burden and determinants of non-medical and opportunity costs of accessing chronic disease care in rural Tanzania. BMJ Open. 2024;14(3):e080466. DOI: 10.1136/bmjopen-2023-080466

Zay Ya K, Lambiris M.J, Levine G.A, Tediosi F, Fink G. Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the Global Survey of Experts on Antimicrobial Resistance. BMC Public Health. 2024;24:2297. DOI: 10.1186/s12889-024-19542-2

Antillón M, Huang C.I, Sutherland S.A, Crump R.E, Bessell P.R, Shaw A.P.M, Tirados I, Picado A, Biéler S, Brown P.E, Solano P, Mbainda S, Darnas J, Wang-Steverding X, Crowley E.H, Peka M, Tediosi F, Rock K.S. Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad. PLoS Negl Trop Dis. 2023;17(7):e0011396. DOI: 10.1371/journal.pntd.0011396

Clausin M, Rieckhoff A, Tediosi F, Morel C.M, Kaspiarovich Y, Levrat N, Wernli D. Multisystemic resilience to shocks: a temporal analysis of health, fundamental rights and freedoms, and economic resilience during the first wave of the COVID-19 pandemic in 22 European countries. BMJ Open. 2023;13(7):e065445. DOI: 10.1136/bmjopen-2022-065445

Evans D.B, Kurowski C, Tediosi F. Health system financing. In: Raviglione M.C.B,Tediosi F,Villa S,Casamitjana N,Plasència A, eds. Global health essentials, 291-295. Cham: Springer International Publishing, 2023. DOI: 10.1007/978-3-031-33851-9_44

Ferrari G, Lwamushi S.M, Balaluka G.B, Lafta R.K, Schindler C, Bugugu D, Lurhangire E, Tediosi F, Mendoza J.R, Merten S. Understanding context of violence against healthcare through citizen science and evaluating the effectiveness of a co-designed code of conduct and of a tailored de-escalation of violence training in Eastern Democratic Republic of Congo and Iraq: a study p. Trials. 2023;24:814. DOI: 10.1186/s13063-023-07839-3

Hooley B, Otchi E.H, Mayeden S, Yawson A.E, Awoonor-Williams K, Tediosi F. Examining the utilization of social capital by Ghanaians when seeking care for chronic diseases: a personal network survey. Int J Public Health. 2023;68:1605891. DOI: 10.3389/ijph.2023.1605891

Lamloum D, Fassio F, Osetinsky B, Tediosi F. Care cascades for hypertension in low-income settings: a systematic review and meta-analysis. Int J Public Health. 2023;68:1606428. DOI: 10.3389/ijph.2023.1606428

Mtenga S, Mhalu G, Osetinsky B, Ramaiya K, Tani K, Hooley B, Tediosi F. Social-political and vaccine related determinants of COVID-19 vaccine hesitancy in Tanzania: a qualitative inquiry. PLOS Glob Public Health. 2023;3(6):e0002010. DOI: 10.1371/journal.pgph.0002010

Osei Afriyie D, Kwesiga B, Achungura G, Tediosi F, Fink G. Effects of health insurance on quality of care in low-income countries: a systematic review. Public Health Rev. 2023;44:1605749. DOI: 10.3389/phrs.2023.1605749

Osei Afriyie D, Masiye F, Tediosi F, Fink G. Confidence in the health system and health insurance enrollment among the informal sector population in Lusaka, Zambia. Soc Sci Med. 2023;321:115750. DOI: 10.1016/j.socscimed.2023.115750

Osei Afriyie D, Masiye F, Tediosi F, Fink G. Purchasing for high-quality care using national health insurance: evidence from Zambia. Health Policy Plan. 2023;38(6):681-688. DOI: 10.1093/heapol/czad022

Osetinsky B, Fink G, Kuwawenaruwa A, Tediosi F. Investigating sustainability challenges for the National Health Insurance Fund in Tanzania: a modelling approach. BMJ Open. 2023;13(8):e070451. DOI: 10.1136/bmjopen-2022-070451

Raviglione M.C.B,Tediosi F,Villa S,Casamitjana N,Plasència A, eds. Global health essentials. Cham: Springer, 2023. DOI: 10.1007/978-3-031-33851-9

Saulnier D.D, Blanchet K, Tediosi F. Health systems resilience. In: Raviglione M.C.B,Tediosi F,Villa S,Casamitjana N,Plasència A, eds. Global health essentials, 355-358. Cham: Springer International Publishing, 2023. DOI: 10.1007/978-3-031-33851-9_54

Saulnier D.D, Duchenko A, Ottilie-Kovelman S, Tediosi F, Blanchet K. Re-evaluating our knowledge of health system resilience during COVID-19: lessons from the first two years of the pandemic. Int J Health Policy Manag. 2023;12:6659. DOI: 10.34172/ijhpm.2022.6659

Tani K, Osetinsky B, Mhalu G, Mtenga S, Fink G, Tediosi F. Healthcare workers' experiences with COVID-19-related prevention and control measures in Tanzania. PLOS Glob Public Health. 2023;3(12):e0002678. DOI: 10.1371/journal.pgph.0002678

Tediosi F, de Savigny D. Global health and systems change. In: Raviglione Mario C.B,Tediosi Fabrizio,Villa Simone,Casamitjana Núria,Plasència Antoni, eds. Global health essentials, 267-271. Cham: Springer International Publishing, 2023. DOI: 10.1007/978-3-031-33851-9_40

Theilmann M, Ginindza N, Myeni J, Dlamini S, Cindzi B.T, Dlamini D, Dlamini T.L, Greve M, Harkare H.V, Hleta M, Khumalo P, Kolbe L.M, Lewin S, Marowa L.R, Masuku S, Mavuso D, Molemans M, Ntshalintshali N, Nxumalo N, Osetinsky B, Pell C, Reis R, Shabalala F, Simelane B.R, Stehr L, Tediosi F, van Leth F, De Neve J.W, Bärnighausen T, Geldsetzer P. Strengthening primary care for diabetes and hypertension in Eswatini: study protocol for a nationwide cluster-randomized controlled trial. Trials. 2023;24:210. DOI: 10.1186/s13063-023-07096-4

Akweongo P, Voetagbe E, Tediosi F, Gadeka D.D, Salari P, Aikins M. Community perceptions of enrolment of indigents into the National Health Insurance Scheme in Ghana: a case study of the Livelihood Empowerment against Poverty Programme. Glob Health Res Policy. 2022;7:4. DOI: 10.1186/s41256-022-00238-2

Antillón M, Huang C.I, Crump R.E, Brown P.E, Snijders R, Mwamba Miaka E, Keeling M.J, Rock K.S, Tediosi F. Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo. Nat Commun. 2022;13:1051. DOI: 10.1038/s41467-022-28598-w

Durizzo K, Harttgen K, Tediosi F, Sahu M, Kuwawenaruwa A, Salari P, Günther I. Toward mandatory health insurance in low-income countries? An analysis of claims data in Tanzania. Health Econ. 2022;31:2187-2207. DOI: 10.1002/hec.4568

Fink G, Tediosi F, Felder S. Burden of Covid-19 restrictions: national, regional and global estimates. EClinicalMedicine. 2022;45:101305. DOI: 10.1016/j.eclinm.2022.101305

Forsgren L, Tediosi F, Blanchet K, Saulnier D.D. Health systems resilience in practice: a scoping review to identify strategies for building resilience. BMC Health Serv Res. 2022;22:1173. DOI: 10.1186/s12913-022-08544-8

Hooley B, Mtenga S, Tediosi F. Informal support networks of Tanzanians with chronic diseases: predictors of support provision and treatment adherence. Int J Public Health. 2022;67:1605366. DOI: 10.3389/ijph.2022.1605366

Hooley B, Osei Afriyie D, Fink G, Tediosi F. Health insurance coverage in low-income and middle-income countries: progress made to date and related changes in private and public health expenditure. BMJ Glob Health. 2022;7(5):e008722. DOI: 10.1136/bmjgh-2022-008722

Michel J, Mohlakoana N, Barnighausen T, Tediosi F, Evans D, McIntyre D, Bressers H.T.A, Tanner M. Testing the contextual Interaction theory in a UHC pilot district in South Africa. BMC Health Serv Res. 2022;22:343. DOI: 10.1186/s12913-022-07705-z

Osei Afriyie D, Krasniq B, Hooley B, Tediosi F, Fink G. Equity in health insurance schemes enrollment in low and middle-income countries: a systematic review and meta-analysis. Int J Equity Health. 2022;21:21. DOI: 10.1186/s12939-021-01608-x

Osetinsky B, Mhalu G, Mtenga S, Tediosi F. Care cascades for hypertension and diabetes: cross-sectional evaluation of rural districts in Tanzania. PLoS Med. 2022;19(12):e1004140. DOI: 10.1371/journal.pmed.1004140

Quaife M, Medley G.F, Jit M, Drake T, Asaria M, van Baal P, Baltussen R, Bollinger L, Bozzani F, Brady O, Broekhuizen H, Chalkidou K, Chi Y.L, Dowdy D.W, Griffin S, Haghparast-Bidgoli H, Hallett T, Hauck K, Hollingsworth T.D, McQuaid C.F, Menzies N.A, Merritt M.W, Mirelman A, Morton A, Ruiz F.J, Siapka M, Skordis J, Tediosi F, Walker P, White R.G, Winskill P, Vassall A, Gomez G.B. Considering equity in priority setting using transmission models: recommendations and data needs. Epidemics. 2022;41:100648. DOI: 10.1016/j.epidem.2022.100648

Wernli D, Tediosi F, Blanchet K, Lee K, Morel C, Pittet D, Levrat N, Young O. A complexity lens on the COVID-19 pandemic. Int J Health Policy Manag. 2022;11(11):2769–2772. DOI: 10.34172/ijhpm.2021.55

Agorinya I.A, Dalaba M, Mensah N.K, Chatio S.T, Le L.M, Bacha Y.D, Sumboh J, Flores G, Edejer T.T, Ross A, Tediosi F, Akazili J. Challenges and experiences in linking community level reported out-of-pocket health expenditures to health provider recorded health expenditures: experience from the iHOPE project in Northern Ghana. PLoS One. 2021;16(9):e0256910. DOI: 10.1371/journal.pone.0256910

Agorinya I.A, Ross A, Flores G, Edejer T.T, Dalaba M.A, Mensah N.K, Le M.L, Dessie Y, Sumboh J, Oduro A.R, Tediosi F. Effect of specificity of health expenditure questions in the measurement of out-of-pocket health expenditure: evidence from field experimental study in Ghana. BMJ Open. 2021;11:e042562. DOI: 10.1136/bmjopen-2020-042562

Aikins M, Tabong P.T, Salari P, Tediosi F, Asenso-Boadi F.M, Akweongo P. Positioning the national health insurance for financial sustainability and universal health coverage in Ghana: a qualitative study among key stakeholders. PLoS One. 2021;16(6):e0253109. DOI: 10.1371/journal.pone.0253109

Akweongo P, Aikins M, Wyss K, Salari P, Tediosi F. Insured clients out-of-pocket payments for health care under the national health insurance scheme in Ghana. BMC Health Serv Res. 2021;21:440. DOI: 10.1186/s12913-021-06401-8

Akweongo P, Chatio S.T, Owusu R, Salari P, Tediosi F, Aikins M. How does it affect service delivery under the National Health Insurance Scheme in Ghana? Health providers and insurance managers perspective on submission and reimbursement of claims. PLoS One. 2021;16(3):e0247397. DOI: 10.1371/journal.pone.0247397

Antillón M, Huang C.I, Rock K.S, Tediosi F. Economic evaluation of disease elimination: an extension to the net-benefit framework and application to human African trypanosomiasis. Proc Natl Acad Sci U S A. 2021;118(50):e2026797118. DOI: 10.1073/pnas.2026797118

Erismann S, Pesantes M.A, Beran D, Leuenberger A, Farnham A, Berger Gonzalez de White M, Labhardt N.D, Tediosi F, Akweongo P, Kuwawenaruwa A, Zinsstag J, Brugger F, Somerville C, Wyss K, Prytherch H. How to bring research evidence into policy? Synthesizing strategies of five research projects in low-and middle-income countries. Health Res Policy Syst. 2021;19:29. DOI: 10.1186/s12961-020-00646-1

Francetic I, Fink G, Tediosi F. Impact of social accountability monitoring on health facility performance: evidence from Tanzania. Health Econ. 2021;30(4):766-785. DOI: 10.1002/hec.4219

Francetic I, Tediosi F, Kuwawenaruwa A. A network analysis of patient referrals in two district health systems in Tanzania. Health Policy Plan. 2021;36(2):162-175. DOI: 10.1093/heapol/czaa138

Galactionova K, Sahu M, Gideon S.P, Puthupalayam Kaliappan S, Morozoff C, Ajjampur S.S.R, Walson J, Rubin Means A, Tediosi F. Costing interventions in the field: preliminary cost estimates and lessons learned from an evaluation of community-wide mass drug administration for elimination of soil-transmitted helminths in the DeWorm3 trial. BMJ Open. 2021;11(7):e049734. DOI: 10.1136/bmjopen-2021-049734

Kuwawenaruwa A, Tediosi F, Metta E, Obrist B, Wiedenmayer K, Msamba V.S, Wyss K. Acceptability of a prime vendor system in public healthcare facilities in Tanzania. Int J Health Policy Manag. 2021;10(10):625-637. DOI: 10.34172/ijhpm.2020.90

Osei Afriyie D, Hooley B, Mhalu G, Tediosi F, Mtenga S.M. Governance factors that affect the implementation of health financing reforms in Tanzania: an exploratory study of stakeholders' perspectives. BMJ Glob Health. 2021;6(8):e005964. DOI: 10.1136/bmjgh-2021-005964

Saulnier D.D, Blanchet K, Canila C, Cobos Muñoz D, Zennaro L.D, De Savigny D, Durski K.N, Garcia F, Grimm P.Y, Kwamie A, Maceira D, Marten R, Peytremann-Bridevaux I, Poroes C, Ridde V, Seematter L, Stern B, Suarez P, Teddy G, Wernli D, Wyss K, Tediosi F. A health systems resilience research agenda: moving from concept to practice. BMJ Glob Health. 2021;6:e006779. DOI: 10.1136/bmjgh-2021-006779

Wernli D, Clausin M, Antulov-Fantulin N, Berezowski J, Biller N, Blanchet K, Böttcher L, Burton-Jeangros C, Escher G, Flahault A, Fukuda K, Helbing D, Jaffé P.D, Søgaard Jørgensen P, Kaspiarovich Y, Krishnakumar J, Lawrence R.J, Lee K, Léger A, Levrat N, Martischang R, Morel C.M, Pittet D, Stauffer M, Tediosi F, Vanackere F, Vassalli J.D, Wolff G, Young O. Building a multisystemic understanding of societal resilience to the COVID-19 pandemic. BMJ Glob Health. 2021;6(7):e006794. DOI: 10.1136/bmjgh-2021-006794

Campbell C.H, Binder S, King C.H, Knopp S, Rollinson D, Person B, Webster B, Allan F, Utzinger J, Ame S.M, Ali S.M, Kabole F, N'Goran E.K, Tediosi F, Salari P, Ouattara M, Diakite N.R, Hattendorf J, Andros T, Kittur N, Colley D.G. SCORE operational research on moving toward interruption of schistosomiasis transmission. Am J Trop Med Hyg. 2020;103(Suppl. 1):58-65. DOI: 10.4269/ajtmh.19-0825

GBD Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1250-1284. DOI: 10.1016/S0140-6736(20)30750-9

GBD Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1135-1159. DOI: 10.1016/S0140-6736(20)31404-5

Kuwawenaruwa A, Tediosi F, Obrist B, Metta E, Chiluda F, Wiedenmayer K, Wyss K. The role of accountability in the performance of Jazia prime vendor system in Tanzania. J Pharm Policy Pract. 2020;13:25. DOI: 10.1186/s40545-020-00220-8

Kuwawenaruwa A, Wyss K, Wiedenmayer K, Metta E, Tediosi F. The effects of medicines availability and stock-outs on household's utilization of healthcare services in Dodoma region, Tanzania. Health Policy Plan. 2020;35(3):323-333. DOI: 10.1093/heapol/czz173

Kuwawenaruwa A, Wyss K, Wiedenmayer K, Tediosi F. Cost and cost drivers associated with setting-up a prime vendor system to complement the national medicines supply chain in Tanzania. BMJ Glob Health. 2020;5(9):e002681. DOI: 10.1136/bmjgh-2020-002681

Le L.M, Flores G, Edejer T.T, Tran T.K, Nguyen C.T.K, Tran D.T, Ho P.D, Agorinya I.A, Tediosi F, Ross A. Investigating the effect of recall period on estimates of inpatient out-of-pocket expenditure from household surveys in Vietnam. PLoS One. 2020;15(11):e0242734. DOI: 10.1371/journal.pone.0242734

Marocco C, Tediosi F, Bangert M, Mupfasoni D, Montresor A. Estimated need for anthelminthic medicines to control soil-transmitted helminthiases in school-aged children, 2020-2030. Infect Dis Poverty. 2020;9(1):48. DOI: 10.1186/s40249-020-00656-9

Michel J, Bärninghausen T, Tediosi F, Evans D, Tanner M. COVID-19: what else would be helpful to know?. J Glob Health Rep. 2020;4:e2020062. DOI: 10.29392/001c.13513

Michel J, Datay M.I, Motsohi T.J, Bärnighausen T, Tediosi F, McIntyre D, Tanner M, Evans D. Achieving universal health coverage in sub-Saharan Africa: the role of leadership development. J Glob Health Rep. 2020;4:e2020037. DOI: 10.29392/001c.12855

Michel J, Mohlakoana N, Bärnighausen T, Tediosi F, McIntyre D, Bressers H.T, Tanner M, Evans D. Varying universal health coverage policy implementation states: exploring the process and lessons learned from a national health insurance pilot site. J Glob Health Rep. 2020;4:e2020036. DOI: 10.29392/001c.12857

Michel J, Obrist B, Bärnighausen T, Tediosi F, McIntyre D, Evans D, Tanner M. What we need is health system transformation and not health system strengthening for universal health coverage to work: perspectives from a National Health Insurance pilot site in South Africa. S Afr Fam Pract. 2020;62(1):a5079. DOI: 10.4102/safp.v62i1.5079

Michel J, Stuckelberger A, Tediosi F, Evans D, Van Eeuwijk P. The roles of grandmother in Africain societies: please do not send them to old people's homes. J Glob Health. 2020;9(1):010306. DOI: 10.7189/jogh.10.010361

Michel J, Tediosi F, Egger M, Bärnighausen T, McIntyre D, Tanner M, Evans D. Universal health coverage financing in South Africa: wishes vs reality. J Glob Health Rep. 2020;4:e2020061. DOI: 10.29392/001c.13509

NTD Modelling Consortium Discussion Group on Gambiense Human African Trypanosomiasis. Insights from quantitative and mathematical modelling on the proposed 2030 goal for gambiense human African trypanosomiasis (gHAT). Gates Open Res. 2020;3:1553. DOI: 10.12688/gatesopenres.13070.1

Sahu M, Tediosi F, Noor A.M, Aponte J.J, Fink G. Health systems and global progress towards malaria elimination, 2000-2016. Malar J. 2020;19:141. DOI: 10.1186/s12936-020-03208-6

Salari P, Fürst T, Knopp S, Rollinson D, Kabole F, Khamis M.I, Omar M.A, Bacon O, Ali S.M, Utzinger J, Tediosi F. Financial costs of the Zanzibar elimination of schistosomiasis transmission project. Am J Trop Med Hyg. 2020;103(6):2260-2267. DOI: 10.4269/ajtmh.20-0252

Salari P, Fürst T, Knopp S, Utzinger J, Tediosi F. Cost of interventions to control schistosomiasis: a systematic review of the literature. PLoS Negl Trop Dis. 2020;14(3):e0008098. DOI: 10.1371/journal.pntd.0008098

Tediosi F, Lonnroth K, Pablos-Mendez A, Raviglione M. Build back stronger universal health coverage systems after the COVID-19 pandemic: the need for better governance and linkage with universal social protection. BMJ Glob Health. 2020;5(10):e004020. DOI: 10.1136/bmjgh-2020-004020

Amstutz A, Lejone T.I, Khesa L, Muhairwe J, Nsakala B.L, Tlali K, Bresser M, Tediosi F, Kopo M, Kao M, Klimkait T, Battegay M, Glass T.R, Labhardt N.D. VIBRA trial - effect of village-based refill of ART following home-based same-day ART initiation vs clinic-based ART refill on viral suppression among individuals living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho. Trials. 2019;20:522. DOI: 10.1186/s13063-019-3510-5

Fiestas Navarrete L, Ghislandi S, Stuckler D, Tediosi F. Inequalities in the benefits of national health insurance on financial protection from out-of-pocket payments and access to health services: cross-sectional evidence from Ghana. Health Policy Plan. 2019;34(9):694-705. DOI: 10.1093/heapol/czz093

Francetic I, Tediosi F, Salari P, de Savigny D. Going operational with health systems governance: supervision and incentives to health workers for increased quality of care in Tanzania. Health Policy Plan. 2019;34(Suppl. 2):ii77-ii92. DOI: 10.1093/heapol/czz104

Jourdan P.M, Tediosi F. The challenge of ensuring equity in mass deworming programmes. Lancet Glob Health. 2019;7(11):e1468-e1469. DOI: 10.1016/S2214-109X(19)30392-4

Missoni E, Pacileo G, Tediosi F. Global health governance and policy: an introduction. London: Routledge, 2019. DOI: 10.4324/9781351188999

Missoni E, Tediosi F. Old and new powers in development assistance in health. In: Olivié I,Pérez A, eds. Aid power and politics, 255-271. London: Routledge, 2019. DOI: 10.4324/9780429440236

Nsiah-Boateng E, Nonvignon J, Aryeetey G.C, Salari P, Tediosi F, Akweongo P, Aikins M. Sociodemographic determinants of health insurance enrolment and dropout in urban district of Ghana: a cross-sectional study. Health Econ Rev. 2019;9:23. DOI: 10.1186/s13561-019-0241-y

Renggli S, Mayumana I, Mshana C, Mboya D, Kessy F, Tediosi F, Pfeiffer C, Aerts A, Lengeler C. Looking at the bigger picture: how the wider health financing context affects the implementation of the Tanzanian Community Health Funds. Health Policy Plan. 2019;34(1):12-23. DOI: 10.1093/heapol/czy091

Salari P, Akweongo P, Aikins M, Tediosi F. Determinants of health insurance enrolment in Ghana: evidence from three national household surveys. Health Policy Plan. 2019;34(8):582-594. DOI: 10.1093/heapol/czz079

Sutherland C.S, Tediosi F. Is the elimination of 'sleeping sickness' affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa. BMJ Glob Health. 2019;4(2):e001173. DOI: 10.1136/bmjgh-2018-001173

Agorinya I.A, Kanmiki E.W, Nonterah E.A, Tediosi F, Akazili J, Welaga P, Azongo D, Oduro A.R. Socio-demographic determinants of low birth weight: evidence from the Kassena-Nankana districts of the Upper East Region of Ghana. PLoS One. 2018;13(11):e0206207. DOI: 10.1371/journal.pone.0206207

Lenk E.J, Redekop W.K, Luyendijk M, Fitzpatrick C, Niessen L, Stolk W.A, Tediosi F, Rijnsburger A.J, Bakker R, Hontelez J.A.C, Richardus J.H, Jacobson J, Le Rutte E.A, De Vlas S.J, Severens J.L. Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: human African trypanosomiasis, leprosy, visceral leishmaniasis, chagas disease. PLoS Negl Trop Dis. 2018;12(3):e0006250. DOI: 10.1371/journal.pntd.0006250

Means A.R, Ajjampur S.S.R, Bailey R, Galactionova K, Gwayi-Chore M.C, Halliday K, Ibikounle M, Juvekar S, Kalua K, Kang G, Lele P, Luty A.J.F, Pullan R, Sarkar R, Schar F, Tediosi F, Weiner B.J, Yard E, Walson J, DeWorm3 Implementation Science Team. Evaluating the sustainability, scalability, and replicability of an STH transmission interruption intervention: the DeWorm3 implementation science protocol. PLoS Negl Trop Dis. 2018;12(1):e0005988. DOI: 10.1371/journal.pntd.0005988

Merritt M.W, Sutherland C.S, Tediosi F. Ethical considerations for global health decision-making: justice-enhanced cost-effectiveness analysis of new technologies for Trypanosoma brucei gambiense. Public Health Ethics. 2018;11(3):275-292. DOI: 10.1093/phe/phy013

Michel J, Evans D, Tediosi F, de Savigny D, Egger M, Bärninghausen T, McIntyre D, Rispel L. Lest we forget, primary health care in sub-Saharan Africa is nurse led. Is this reflected in the current health systems strengthening undertakings and initiatives?. J Glob Health Rep. 2018;2:e2018009. DOI: 10.29392/joghr.2.e2018009

Renggli S, Mayumana I, Mboya D, Charles C, Maeda J, Mshana C, Kessy F, Tediosi F, Pfeiffer C, Schulze A, Aerts A, Lengeler C. Towards improved health service quality in Tanzania: An approach to increase efficiency and effectiveness of routine supportive supervision. PLoS One. 2018;13(9):e0202735. DOI: 10.1371/journal.pone.0202735

Aerts C, Sunyoto T, Tediosi F, Sicuri E. Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature. Health Policy. 2017;121(7):745-754. DOI: 10.1016/j.healthpol.2017.05.005

Fürst T, Salari P, Llamas L.M, Steinmann P, Fitzpatrick C, Tediosi F. Global health policy and neglected tropical diseases: then, now, and in the years to come. PLoS Negl Trop Dis. 2017;11(9):e0005759. DOI: 10.1371/journal.pntd.0005759

Galactionova K, Tediosi F, Camponovo F, Smith T.A, Gething P.W, Penny M.A. Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa. Vaccine. 2017;35(1):53-60. DOI: 10.1016/j.vaccine.2016.11.042

Galactionova K, Tediosi F. DeWorm3 Economic Evaluation Protocol. Basel: Swiss Tropical and Public Health Institute, 2017

Galactionova K, Tediosi F. Cost collection tool supporting economic evaluation along DeWorm3 trial. Basel: Swiss Tropical and Public Health Institute, 2017

GBD Health Financing Collaborator Network. Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet. 2017;389(10083):1981-2004. DOI: 10.1016/S0140-6736(17)30874-7

Kastner R.J, Sicuri E, Stone C.M, Matwale G, Onapa A, Tediosi F. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis. PLoS Negl Trop Dis. 2017;11(9):e0005934. DOI: 10.1371/journal.pntd.0005934

Kim Y.E, Stolk W.A, Tanner M, Tediosi F. Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa. BMJ Glob Health. 2017;2(2):e000158. DOI: 10.1136/bmjgh-2016-000158

Redekop W.K, Lenk E.J, Luyendijk M, Fitzpatrick C, Niessen L, Stolk W.A, Tediosi F, Rijnsburger A.J, Bakker R, Hontelez J.A, Richardus J.H, Jacobson J, de Vlas S.J, Severens J.L. The socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases. PLoS Negl Trop Dis. 2017;11(1):e0005289. DOI: 10.1371/journal.pntd.0005289

Sutherland C.S, Stone C.M, Steinmann P, Tanner M, Tediosi F. Seeing beyond 2020: an economic evaluation of contemporary and emerging strategies for elimination of Trypanosoma brucei gambiense. Lancet Glob Health. 2017;5(1):e69-e79. DOI: 10.1016/S2214-109X(16)30237-6

Tediosi F, Lengeler C, Castro M, Shretta R, Levin C, Wells T, Tanner M. Malaria control. In: Holmes K.K,Bertozzi S,Bloom R,Jha P, eds. Diseases control priorities, 347-364. Washington, DC: World Bank, 2017

The malERA Refresh Consultative Panel on Health Systems and Policy Research. malERA: an updated research agenda for health systems and policy research in malaria elimination and eradication. PLoS Med. 2017;14(11):e1002454. DOI: 10.1371/journal.pmed.1002454

Kastner R.J, Stone C.M, Steinmann P, Tanner M, Tediosi F. Lessons learned from developing an eradication investment case for lymphatic filariasis. Adv Parasitol. 2016;94:393-417. DOI: 10.1016/bs.apar.2016.08.004

Stone C.M, Kastner R, Steinmann P, Chitnis N, Tanner M, Tediosi F. Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage. BMJ Global Health. 2016;1:e000021. DOI: 10.1136/bmjgh-2015-000021

Tediosi F, Finch A, Procacci C, Marten R, Missoni E. BRICS countries and the global movement for universal health coverage. Health Policy Plan. 2016;31(6):717-728. DOI: 10.1093/heapol/czv122

Tediosi F, Penny M. Evidence for optimal allocation of malaria interventions in Africa [Comment]. Lancet Global Health. 2016;4(7):e432-e433. DOI: 10.1016/S2214-109X(16)30108-5

Bailey T.C, Merritt M.W, Tediosi F. Investing in justice: ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis. Am J Public Health. 2015;105(4):629-636. DOI: 10.2105/AJPH.2014.302454

Galactionova K, Bertram M, Lauer J, Tediosi F. Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: a generalizable approach drawing on publicly available data. Vaccine. 2015;33(48):6710-6718. DOI: 10.1016/j.vaccine.2015.10.079

Galactionova K, Tediosi F, de Savigny D, Smith T, Tanner M. Effective coverage and systems effectiveness for malaria case management in sub-Saharan African countries. PLoS One. 2015;10(5):e0127818. DOI: 10.1371/journal.pone.0127818

Galactionova K, Tediosi F, de Savigny D, Smith T, Tanner M. Effective coverage and systems effectiveness for malaria case management in sub-Saharan African countries. Trop Med Int Health, 2015;20(Suppl. 1):137-138

GBD 2013 DALYs Collaborators, HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145-2195. DOI: 10.1016/S0140-6736(15)61340-X

Kastner R, Stone C, Steinmann P, Tediosi F. What is needed to eradicate lymphatic filariasis? A model-based assessment on the impact of scaling up mass drug administration programs. Trop Med Int Health, 2015;20(Suppl. 1):229

Kastner R.J, Stone C.M, Steinmann P, Tanner M, Tediosi F. What is needed to eradicate lymphatic filariasis? A model-based assessment on the impact of scaling up mass drug administration programs. PLoS Negl Trop Dis. 2015;9(10):e0004147. DOI: 10.1371/journal.pntd.0004147

Keating J, Yukich J.O, Sutherland C.S, Woods G, Tediosi F. Human African trypanosomiasis prevention, treatment and control costs: a systematic review. Acta Trop. 2015;150:4-13. DOI: 10.1016/j.actatropica.2015.06.003

Kim Y.E, Remme J.H.F, Steinmann P, Stolk W.A, Roungou J.B, Tediosi F. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa. PLoS Negl Trop Dis. 2015;9(4):e0003664. DOI: 10.1371/journal.pntd.0003664

Kim Y.E, Sicuri E, Tediosi F. Financial and economic costs of the elimination and eradication of onchocerciasis (river blindness) in Africa. PLoS Negl Trop Dis. 2015;9(9):e0004056. DOI: 10.1371/journal.pntd.0004056

Kim Y.E, Sicuri E, Tediosi F. Onchocerciasis (river blindness) in Africa: alternative strategies, treatment needs and costs. Trop Med Int Health, 2015;20(Suppl. 1):317-318

Medin E, Goude F, Melberg H.O, Tediosi F, Belicza E, Peltola M. European regional differences in all-cause mortality and length of stay for patients with hip fracture. Health Econ. 2015;24(Suppl 2):53-64. DOI: 10.1002/hec.3278

Numerato D, Fattore G, Tediosi F, Zanini R, Peltola M, Banks H, Mihalicza P, Lehtonen L, Svereus S, Heijink R, Klitkou S.T, Fletcher E, Heijden Av, Lundberg F, Over E, Hakkinen U, Seppala T.T. Mortality and length of stay of very low birth weight and very preterm infants: a EuroHOPE study. PLoS One. 2015;10(6):e0131685. DOI: 10.1371/journal.pone.0131685

Patouillard E, Griffin J, Bah A, Gething P, Shutes E, Bhatt S, Prabasi S, Alonso P, Tediosi F, Ghani A, Cibulskis R.E. Feasibility, costs and benefits of the Global Technical Strategy 2016-2030 for accelerating global progress towards malaria elimination. Trop Med Int Health, 2015;20(Suppl. 1):104. Abstracts of the 9th European Congress on Tropical Medicine and International Health, 6-10 September 2015, Basel, Switzerland

Pillai N, Obure C, Tediosi F. Pragmatically and routinely costing malaria: reflections on practical experience in Ghana and Tanzania. Trop Med Int Health, 2015;20(Suppl. 1):379. Abstracts of the 9th European Congress on Tropical Medicine and International Health, 6-10 September 2015, Basel, Switzerland

Sicuri E, Evans D.B, Tediosi F. Can economic analysis contribute to disease elimination and eradication? A systematic review. PLoS One. 2015;10(6):e0130603. DOI: 10.1371/journal.pone.0130603

Steinmann P, Stone C.M, Sutherland C.S, Tanner M, Tediosi F. Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei brucei gambiense. Trop Med Int Health. 2015;20(6):707-718. DOI: 10.1111/tmi.12483.

Sutherland C.S, Stone C.M, Tediosi F. Seeing beyond 2020: cost-effectiveness analysis of contemporary and emerging strategies for human African trypanosomiasis (HAT) Trypanosoma brucei (T.b.) gambiense for elimination. Trop Med Int Health, 2015;20(Suppl. 1):103-104. Abstracts of the 9th European Congress on Tropical Medicine and International Health, 6-10 September 2015, Basel, Switzerland

Sutherland C.S, Stone C.M, Tediosi F. Modelling health systems implications of current and emerging technologies for HAT Trypanosoma brucei (T.b.) gambiense. Trop Med Int Health, 2015;20(Suppl. 1):336

Sutherland C.S, Yukich J, Goerre R, Tediosi F. A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness"). PLoS Negl Trop Dis. 2015;9(2):e0003397. DOI: 10.1371/journal.pntd.0003397

Gabriele S, Tediosi F. Intergovernmental relations and long term care reforms: lessons from the Italian case. Health Policy. 2014;116(1):61-70. DOI: 10.1016/j.healthpol.2014.01.005

Galactionova K, Tediosi F, Smith T.A, Penny M.A. Projected cost-effectiveness of RTS,S vaccination in 43 sub-Saharan African countries. Am J Trop Med Hyg, 2014;91(5 Suppl. 1):484-485

Galactionova K, Tediosi F, Smith T.A, Penny M.A. Distribution impact of RTS,S vaccination in sub-Saharan Africa: implications for policy implementation. Am J Trop Med Hyg, 2014;91(5 Suppl. 1):303

Galactionova K, Tediosi F. Methodology to estimate the cost of introducing RTS,S vaccine into national immunization program in sub-Saharan African countries. Am J Trop Med Hyg, 2014;91(5 Suppl. 1):485

Gautier L, Harmer A, Tediosi F, Missoni E. Reforming the World Health Organization: what influence do the BRICS wield?. Contemp Politics. 2014;20(2):163-181. DOI: 10.1080/13569775.2014.907987

Keating J, Yukich J.O, Mollenkopf S, Tediosi F. Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review. Acta Trop. 2014;135:86-95. DOI: 10.1016/j.actatropica.2014.03.017

Kim Y.E, Sicuri E, Tediosi F. Financial and economic costs for control, elimination and eradication of river blindness in Africa. Am J Trop Med Hyg, 2014;91(5 Suppl. 1):178-179

McKee M, Marten R, Balabanova D, Watt N, Huang Y, Finch A.P, Fan V.Y, Van Damme W, Tediosi F, Missoni E. BRICS' role in global health and the promotion of universal health coverage: the debate continues. Bull World Health Organ. 2014;92(6):452-453. DOI: 10.2471/BLT.13.132563

Missoni E, Tediosi F, Pacileo G, Gautier L. Italy's contribution to global health: the need for a paradigm shift. Global Health. 2014;10:25. DOI: 10.1186/1744-8603-10-25

Missoni E, Tediosi F. Oms e copertura universale, il gruppo "Brics" diviso alla meta [Editorial]. Sole 24 Ore Sanità. 2014(29):15

Numerato D, Fattore G, Tediosi F, Zanini R, Fletcher E, Häkkinen U, Heijink R, van der Heijden A, Iversen T, Klitkou S.T, Mihalicza P, Peltola M, Seppälä T.T, Sveréus S, Banks H. EuroHOPE very low birth weight (VLBW) and very low gestational age (VLGA) infants: material, methods and indicators. Helsinki: EuroHOPE, 2014

Saksena P, Smith T, Tediosi F. Inputs for universal health coverage: a methodological contribution to finding proxy indicators for financial hardship due to health expenditure. BMC Health Serv Res. 2014;14:577. DOI: 10.1186/s12913-014-0577-2

Sutherland C.S, Stone C, Tediosi F. Health systems modelling-demonstrating the poteltial impact of diagnostic and treatment integration of human African trypanosomiasis using different health system structures. Am J Trop Med Hyg, 2014;91(5 Suppl. 1):327-328

Crowell V, Levin A, Galactionova K, Tediosi F. Costing and budgeting for malaria service delivery. Basel: Swiss Tropical and Public Health Institute, 2013

Fattore G, Tediosi F. The importance of values in shaping how health systems governance and management can support universal health coverage. Value Health. 2013;16(Suppl. 1):S19-S23. DOI: 10.1016/j.jval.2012.10.008

Garcia C.R, Manzi F, Tediosi F, Hoffman S.L, James E.R. Comparative cost models of a liquid nitrogen vapor phase (LNVP) cold chain-distributed cryopreserved malaria vaccine vs. a conventional vaccine. Vaccine. 2013;31(2):380-386. DOI: 10.1016/j.vaccine.2012.10.109

Harmer A, Xiao Y, Missoni E, Tediosi F. 'BRICS without straw'? A systematic literature review of newly emerging economies' influence in global health. Global Health. 2013;9:15. DOI: 10.1186/1744-8603-9-15

Kastner R, Stone C, Steinmann P, Chitnis N, Tediosi F. Scenarios for lymphatic filariasis eradication and the associated impact on demand for MDA. Trop Med Int Health, 2013;18(Suppl. 1):122

Kastner R, Stone C, Steinmann P, Tediosi F. Scenarios for lymphatic filariasis eradication and the associated impact on number of treatments needed. Am J Trop Med Hyg, 2013;89(5 Suppl.):319

Kim Y.E, Remme J.H.F, Steinmann P, Tediosi F. Forecasting demand for onchocerciasis treatment to achieve elimination and eradication. Am J Trop Med Hyg, 2013;89(5 Suppl.):445

Mikkelsen-Lopez I, Tediosi F, Abdallah G, Njozi M, Amuri B, Khatib R, Manzi F, de Savigny D. Beyond antimalarial stock-outs: implications of health provider compliance on out-of-pocket expenditure during care-seeking for fever in south east Tanzania. BMC Health Serv Res. 2013;13:444. DOI: 10.1186/1472-6963-13-444

Missoni E,Tediosi F, eds. Education in global health policy and management. Milano: Egea, 2013

Penny M, Galactionova K, Tediosi F, Maire N, Tarantino M, Briët O, Smith T. Public health impact and cost-effectiveness of the RTS,S malaria vaccine: modelling and simulation results. Washington: PATH Malaria Vaccine Initiative, 2013

Shieh M, Thompson C, Phan Vu Tra M, Thi Thuy Linh V, Tediosi F, Merson L, Farrar J.J, Manh Tuan H, Lu Viet H, Thi Ngoc Tuyet P, Baker S. The policy of free healthcare for children under the age of 6 years in Vietnam: assessment of the uptake for children hospitalised with acute diarrhoea in Ho Chi Minh City. Trop Med Int Health. 2013;18(12):1444-1451. DOI: 10.1111/tmi.12208

Stone C, Kastner R, Steinmann P, Chitnis N, Tediosi F. Health impact analysis of lymphatic filariasis elimination vs. eradication scenarios. Am J Trop Med Hyg, 2013;89(5 Suppl.):318

Tediosi F, de Savigny D. Il pensiero sistemico per trasformare la salute globale. In: Cattaneo A,Dentico N, eds. OMS e diritto alla salute : quale futuro : 5 rapporto dell'Osservatorio Italiano sulla Salute Globale, 217-230. Bologna: Osservatorio Italiano sulla Salute Globale, 2013

Tediosi F, Elisa S. Disease eradication: is an economic perspective useful?. Am J Trop Med Hyg, 2013;89(5 Suppl.):189

Tediosi F, Eun Kim Y, Sicuri E, Steinmann P, Stolk W.A, Remme J.H.F, Tanner M. Eradication investment case for onchocerciasis. Am J Trop Med Hyg, 2013;89(5 Suppl.):89

Tediosi F, Steinmann P, de Savigny D, Tanner M. Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges. PLoS Negl Trop Dis. 2013;7(11):e2446. DOI: 10.1371/journal.pntd.0002446

Tediosi F. Il razionale e la logica delle valutazioni economiche in prevenzione. In: Cislaghi C,Ricciardi W, eds. Rapporto prevenzione 2013: l'economia della prevenzione, 89-110. Bologna: Il Mulino, 2013

Compagni A, Tediosi F. Implementing performance based funding for health research: when governance and procedural fairness matter. Public Adm. 2012;90(2):313-334. DOI: 10.1111/j.1467-9299.2011.01965.x

Galactionova K, Tediosi F, Boutsika K. Methods for costing malaria service delivery using secondary data. Malar J, 2012;11(Suppl 1):S31

Smith T, Tediosi F. Simulating the impact of malaria vaccination: what has been learnt?. Expert Rev Vaccines. 2012;11(7):751-753. DOI: 10.1586/ERV.12.51

Tediosi F. Sanità, invecchiamento e nuove tecnologie. nelMerito. com. 2012;24 dicembre 2012:1-3

Gabriele S, Tanda P, Tediosi F. The impact of long-term care on caregivers' participation in the labour market. Brussels: European Network of Economic Policy Research Institutes, 2011

Maire N, Shillcutt S.D, Walker D.G, Tediosi F, Smith T.A. Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in Sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum . Value Health. 2011;14(8):1028-1038. DOI: 10.1016/j.jval.2011.06.004

Missoni E,Tediosi F, eds. Per una sanità universale: responsabilità globale, soluzioni locali. Roma: Il Pensiero Scientifico, 2011

Ricciuti E, Tediosi F. Mobilità sanitaria europea e diritti dei pazienti: l'impatto della direttiva 2011/24/UE sul SSN. In: Cantù E, ed. Rapporto OASI 2011: l'aziendalizzazione della sanità in Italia, 201-222. Milano: Egea, 2011

Sicuri E, Biao P, Hutton G, Tediosi F, Menendez C, Lell B, Kremsner P, Conteh L, Grobusch M.P. Cost-effectiveness of intermittent preventive treatment of malaria in infants (IPTi) for averting anaemia in Gabon: a comparison between intention to treat and according to protocol analyses. Malar J. 2011;10:305. DOI: 10.1186/1475-2875-10-305

Compani A, Tediosi F, Tozzi V.D. L'integrazione fra ospedale e territorio nelle Aziende Sanitarie. Rapporto OASI 2010, 519-542. Milano: Egea, 2010

Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, Biao P, Masika P, Matovu F, Otieno P, Gosling R.D, Hamel M, Odhiambo F.O, Grobusch M.P, Kremsner P.G, Chandramohan D, Aponte J.J, Egan A, Schellenberg D, Macete E, Slutsker L, Newman R.D, Alonso P, Menendez C, Tanner M. The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PLoS One. 2010;5(6):e10313. DOI: 10.1371/journal.pone.0010313

Fattore G, Tediosi F. Attaining universal health coverage: the role of governance and management. In: Missoni E, ed. Attending universal health coverage: a research initiative to support evidence-based advocacy and policy, 1-21. Milano: Bocconi University, 2010

Mosha J.F, Conteh L, Tediosi F, Gesase S, Bruce J, Chandramohan D, Gosling R. Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS One. 2010;5(1):e8707. DOI: 10.1371/journal.pone.0008707

Tediosi F, Compagni A. Analisi del sistema di finanziamento della ricerca sanitaria in Italia. Milano: Franco Angeli, 2010

Tediosi F, Gabriele S. Long-term care in Italy: work package 1: overview of long care systems. Country repot: Italy. Brussels: European Network of Economic Policy Research Institutes, 2010

Tediosi F. Gli aiuti allo sviluppo per la salute negli ultimi anni. Salute globale InFormAzione per cambiare: quarto Rapporto dell'Osservatorio italiano sulla salute globale, 95-106. Pisa: ETS, 2010

Ceda C, Fosti G, Tediosi F. Fondo per le non autosufficienze: implicazioni per la governance dei servizi socio-sanitari regionali e locali. Rapporto OASI 2009, 289-309. Milano: Egea, 2009

Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B, Mas X, Trapero M, Tanner M, Trilla A, Alonso P, Menendez C. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bull World Health Organ. 2009;87(2):123-129

Longo F, Tediosi F. Servizi per la non autosufficienza: un quadro regionale frammentato. Rapporto ISAE: finanza pubblica e istituzioni, 77-97. Roma: ISAE, 2009

Missoni E, Tediosi F, Fattore G, Pacileo G, Ricciuti E. Attaining Universal Health Coverage: a research initiative to support evidence based advocacy and policy making: concept paper. Milano: Egea, 2009

Missoni E, Tediosi F, Pacileo G, Borgonovi E. G8 Summit 2009: what approach will Italy take to health?. Lancet. 2009;374(9683):9-10. DOI: 10.1016/S0140-6736(09)61216-2

Tediosi F, Gabriele S, Longo F. Governing decentralization in health care under tough budget constraint: what can we learn from the Italian experience?. Health Policy. 2009;90(2-3):303-312. DOI: 10.1016/j.healthpol.2008.10.012

Tediosi F, Maire N, Penny M, Studer A, Smith T.A. Simulation of the cost-effectiveness of malaria vaccines. Malar J. 2009;8:127. DOI: 10.1186/1475-2875-8-127

Tediosi F. Research today, money tomorrow, and the vaccine takes off. Bocconi online newsmagazine. 2009(17.11.2009)

Tediosi Fabrizio. Simulation of the costs and consequences of potential vaccines for Plasmodiun falciparum malaria. Basel: Univ. Basel, 2009. Doctoral Thesis, University of Basel, Faculty of Science DOI: 10.5451/unibas-005246042

Wiedenmayer K.A, Weiss S, Chattopadhyay C, Mukherjee A, Kundu R, Ayé R, Tediosi F, Hetzel M.W, Tanner M. Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: evidence from a comparative time-motion study in India. Vaccine. 2009;27(5):655-659. DOI: 10.1016/j.vaccine.2008.11.045

Yukich J.O, Zerom M, Ghebremeskel T, Tediosi F, Lengeler C. Costs and cost-effectiveness of vector control in Eritrea using insecticide-treated bed nets. Malar J. 2009;8:51. DOI: 10.1186/1475-2875-8-51

Murru M, Tediosi F. L'aiuto pubblico allo sviluppo e la cooperazione sanitaria. Salute globale e aiuti allo sviluppo: diritti, ideologie, inganni : terzo Rapporto dell'Osservatorio italiano sulla salute globale, 47-77. Pisa: ETS, 2008

Smith T, Maire N, Ross A, Penny M, Chitnis N, Schapira A, Studer A, Genton B, Lengeler C, Tediosi F, de Savigny D, Tanner M. Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology. 2008;135(13):1507-1516

Tediosi F, Ayé R, Ibodova S, Thompson R, Wyss K. Access to medicines and out of pocket payments for primary care: evidence from family users in rural Tajikistan. BMC Health Serv Res. 2008;8:109

Tediosi F, Paradiso M. Il controllo della spesa sanitaria e la credibilità dei piani di rientro. Rapporto ISAE: finanza pubblica e istituzioni, 125-144. Roma: ISAE, 2008

Yukich J.O, Lengeler C, Tediosi F, Brown N, Mulligan J.A, Chavasse D, Stevens W, Justino J, Conteh L, Maharaj R, Erskine M, Mueller D.H, Wiseman V, Ghebremeskel T, Zerom M, Goodman C, McGuire D, Urrutia J.M, Sakho F, Hanson K, Sharp B. Costs and consequences of large-scale vector control for malaria. Malar J. 2008;7:258

Bernasconi J.L, Tediosi F. Current issues and future challenges in health SWAps: fiduciary risk assessment and financial management - issues note. Basel: Swiss Tropical Institute, 2007

Carinci F, Roti L, Francesconi P, Gini R, Tediosi F, Di Iorio T, Bartolacci S, Buiatti E. The impact of different rehabilitation strategies after major events in the elderly: the case of stroke and hip fracture in the Tuscany region. BMC Health Serv Res. 2007;7:95. DOI: 10.1186/1472-6963-7-95

Gabriele S, Tediosi F. Deficit sanitari e federalismo "guidato". Eguaglianza & Libertà online. 2007(22.06.2007)

Mahon J, Tediosi F. Health SWAP in Tajikistan: prospects and suggested next steps. Tajikistan: Swiss Development Cooperation, 2007

Tediosi F. Exploring the potential financial and economic implications of a fully liquid DTP-HepB-Hib vaccine: an assessment for South Africa. Basel: Novartis Vaccines, 2007

Yukich J, Tediosi F, Lengeler C. Operations, costs and cost-effectiveness of five insecticide-treated net programs (Eritrea, Malawi, Tanzania, Togo, Senegal) and two indoor residual spraying programs (Kwa-Zulu-Natal, Mozambique). Basel: Swiss Tropical Institute, 2007

Yukich J, Tediosi F, Lengeler C. Comparative cost-effectiveness of ITNs or IRS in Sub-Saharan Africa. Malaria matters. 2007(18):2-4

Gabriele S, Cislaghi C, Costantini F, Innocenti F, Lepore V, Tediosi F, Valerio M, Zocchetti C. Demographic factors and health expenditure profiles by age: the case of Italy. Brussels: European Network of Economic Policy Research Institutes, 2006

Hutton G, Rehfuess E, Tediosi F, Weiss S. Evaluation of the costs and benefits of household energy and health interventions at global and regional levels. Geneva: WHO, 2006

Hutton G, Rehfuess E, Tediosi F, Weiss S. Evaluation of the costs and benefits of household energy and health interventions at global and regional levels - Summary. Geneva: WHO, 2006

Hutton G, Tediosi F. The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania. Am J Trop Med Hyg. 2006;75(Suppl. 2):119-130

Maciocco G, Tediosi F. Le diseguaglianze nella salute: il caso degli Stati Uniti. 2° Rapporto dell'Osservatorio Italiano sulla Salute Globale. Pisa: ETS, 2006

Magnussen J, Tediosi F, Mihályi P. Effects of decentralization and recentralization on economic dimensions of health systems. In: Saltman R.B,Bankauskaite V,Vrangbaek K, eds. Decentralization in health care: strategies and outcomes, 105-119. Maidenhead: Open University Press, 2006

Maire N, Tediosi F, Ross A, Smith T. Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in Sub-Saharan Africa. Am J Trop Med Hyg. 2006;75(Suppl. 2):111-118

Smith T, Killeen G, Maire N, Ross A, Molineaux L, Tediosi F, Hutton G, Utzinger J, Dietz K, Tanner M. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: overview. Am J Trop Med Hyg. 2006;75(Suppl. 2):1-10

Tediosi F, Hutton G, Maire N, Smith T, Ross A, Tanner M. Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania. Am J Trop Med Hyg. 2006;75(Suppl. 2):131-143

Tediosi F, Maire N, Smith T, Hutton G, Utzinger J, Ross A, Tanner M. An approach to model the costs and effects of case management of Plasmodium falciparum malaria in Sub-Saharan Africa. Am J Trop Med Hyg. 2006;75(Suppl. 2):90-103

Tediosi F, Thompson R. Recent development in health financing reforms in Tajikistan and PHC capitation payments in Varzob and Dangara. Tajikistan: Ministry of Health, 2006

Tediosi F, Thompson R. Health financing reforms in Tajikistan: structures and systems at rayon level required for implementing capitated payments. Tajikistan: Ministry of Health, 2006

Tediosi F, Wiedenmayer K, Weiss S. Economic study on a fully liquid pentavalent vaccine. Basel: Novartis Vaccines, 2006

Tediosi F. Le conseguenze economiche della Malaria. Economia & Politica del Farmaco. 2006;3(8):29-38

Tediosi F. Health financing reforms in Tajikistan: capitated budget allocation for 2007 in project Sino pilot rayons. Tajikistan: Ministry of Health, 2006

Wiedenmayer K, Weiss S, Tediosi F. Time-motion study of a fully liquid pentavalent vaccine in Calcutta, India. Basel: Novartis Vaccines, 2006

Aponte J, Costa J, Dietz D, Hutton G, Killeen G, Maire N, Molineaux L, Raddatz G, Ross A, Smith T, Tanner M, Tediosi F, Utzinger J, Vounatsou P. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: phase A report to MVI at PATH. Basel: Swiss Tropical Institute, 2005

Tediosi F, Ayé R. Patient satisfaction survey in the district of Varzob and Dangara. Tajikistan: Ministry of Health, 2005

Tediosi F, Costa J. The financial and economic implications of implementing a Basic Benefit Package in Tajikistan: Ministry of Health, 2005

Tediosi F. Revising co-payments for hospital care in Tajikistan. Tajikistan: Ministry of Health, 2005

Tediosi F. On implementing the Basic Benefit Package and the capitation in Tajikistan. Tajikistan: Ministry of Health, 2005

Tediosi F, Bartolacci S, Roti L, Buiatti E. L'ospedalizzazione per fratture osteoporotiche in Toscana. Politiche Sanitarie. 2004;5(2):61-69

Tediosi F, Roti L. Gli ospedali di comunità in Toscana: analisi degli aspetti strutturali, organizzativi, di attività e dei costi. Mecosan. 2004;3(51):101-113

Cislaghi C, Galanti C, Tediosi F. La remunerazione delle prestazioni sanitarie: principi e modelli. Annali di Igiene. 2003;15(5):443-456

Cislaghi C, Pisani E, Tediosi F. L'allocazione delle risorse alle Aziende Sanitarie Locali: il caso della regione Toscana. Mecosan. 2003;12(45):45-58

Maciocco G, Tediosi F. Il sistema sanitario americano: l'implosione dietro l'angolo. Prospettive sociali e sanitarie. 2003;33(19):1-23

Tediosi F, Bartolacci S, Roti L, Buiatti E. La valutazione economica dei percosi assistenziali dei soggetti con Ictus e Frattura del femore in Toscana: risultati di uno studio pilota. Mecosan. 2003;12(48):67-82

Toniiolo F, Cislaghi C, Cobello F, Tediosi F. Alcune considerazioni relative al "modello Fiuggi" per il riparto interregionale delle risorse sanitarie. Politiche Sanitarie. 2003(3):82-93

Campi R, Garattini L, Tediosi F, Bonati M. Pharmacoeconomic analysis of prescriptions in Italian pediatric general practice. Eur J Health Econ. 2002;3(4):261-266. DOI: 10.1007/s10198-002-0116-7

Garattini L, Rossi C, Tediosi F, Cornaggia C, Covelli G, Barbui C, Parazzini F, Gruppo Studio SCORE. Costi diretti della schizofrenia nei dipartimenti di salute mentale italiani. ParmacoEconomics. 2002;4(2):81-89

Tediosi F, Forni S, Cislaghi C. Prevalenza di consumatori di farmaci e spesa farmaceutica: un confronto a livello regionale. Ricerca & Pratica. 2002(18):218-227

Tediosi F. Investire in salute nei paesi poveri. Prospettive sociali e sanitarie. 2002;32(12):5-11

Tediosi F. Il rapporto "Macroeconomics and health: investing in health for economic development". Salute e Sviluppo. 2002(1)

Bartolacci S, Berni R, Forni S, Tediosi F, Cislaghi C. Il valore economico dell'ospedalizzazione in funzione del tempo dalla nascita e dalla morte. Politiche Sanitarie. 2001(4-6):193-203

Garattini L, Cornago D, Tediosi F. A comparative analysis of domiciliary oxygen therapy in five European countries. Health Policy. 2001;58(2):133-149

Garattini L, Rossi C, Tediosi F, Cornaggia C, Covelli G, Barbui C, Parazzini F. Direct costs of schizophrenia in Italian community psychiatric services. Pharmacoeconomics. 2001;19(12):1217-1225

Garattini L, Tediosi F, Chiaffarino F, Roggeri D, Parazzini F, Coscelli C. The outpatient cost of diabetes care in Italian diabetes centers. Value Health. 2001;4(3):251-257

Garattini L, Tediosi F, Di Cintio E, Yin D, Parazzini F. Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy. AIDS Care. 2001;13(6):733-741. DOI: 10.1080/09540120120076896

Lucca U, Tediosi F, Tettamanti M. Dimensione epidemiologica e impatto economico delle demenze in Italia. Milano: Emme, 2001

Tediosi F, Bertolini G, Parazzini F, Mecca G, Garattini L. Cost analysis of dialysis modalities in Italy. Health Serv Manage Res. 2001;14(1):9-17

Tediosi F, Forni S, Cislaghi C. Toscana e Lombardia: due sistemi sanitari a confronto. Toscana medica. 2001;19(8):15-31

Garattini L, Ghislandi S, Tediosi F. L'inclusione dei costi indiretti nelle valutazioni economiche: la situazione italiana. Mecosan. 2000;9(24):89-94

Garattini L, Tediosi F, Ghislandi S, Orzella L, Rossi C. How do Italian pharmacoeconomists evaluate indirect costs?. Value Health. 2000;3(4):270-276. DOI: 10.1046/j.1524-4733.2000.34004.x

Garattini L, Tediosi F. A comparative analysis of generics markets in five European countries. Health Policy. 2000;51(3):149-162

Garattini L, Tediosi F. Economia sanitaria e farmaci generici. Milano: K2, 2000

Ricci E, Ruggeri D, Tediosi F, Beghi E, Garattini L. The cost of epilepsy care in referral centers in Italy. HEPAC. 2000;1(1):111-115

Tediosi F, Chiaffarino F, Parazzini F, Coscelli L, Garattini L. I costi del piede diabetico in Italia: dati dal progetto RECORD. Pharmacoeconomics. 2000;2(1):23-28

Tediosi F, Parazzini F, Bortolotti A, Garattini L, Gruppo di Studio Incontinenza. The cost of urinary incontinence in Italian women: a cross-sectional study. Pharmacoeconomics. 2000;17(1):71-76

Orzella L, Tediosi F, Garattini L. La valutazione dei costi ospedalieri in un reparto di malattie infettive: il caso degli Ospedali Riuniti di Bergamo. Agenzia Sanitaria Italiana. 1999(40):22-28

Pagano E, Brunetti M, Tediosi F, Garattini L. Costs of diabetes: a methodological analysis of the literature. Pharmacoeconomics. 1999;15(6):583-595

Tediosi F, Garattini L. I dispositivi medici in Europa. Agenzia Sanitaria Italiana. 1999(50):12-18

Tediosi F, Garattini L. Il servizio sanitario Danese. Agenzia Sanitaria Italiana. 1999(38):6-9

Tediosi F, Mallet J.O, Garattini L. Il sistema sanitario francese (2a parte). Agenzia Sanitaria Italiana. 1999(44):22-30

Tediosi F, Mallet J.O, Garattini L. Il sistema sanitario francese (1a parte). Agenzia Sanitaria Italiana. 1999(43):20-26

Tediosi F, Fattore G, Garattini L. Il razionamento in sanità: riflessioni su alcune esperienze estere. Agenzia Sanitaria Italiana. 1998(35-36):5-12

Tediosi F, Garattini L. Utilizzo dei modelli nelle valutaioni economiche in sanità: cenni teorici e problemi pratici. FarmacoEconomia. 1998(3):21-30

Tediosi F, Pagano E, Garattini L. I costi della schizofrenia: un'analisi metodologica della letteratura esistente. Bollettino Scientifico Informazione. 1998(5):41-47